NCT02063217View on ClinicalTrials.gov

Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Amyloid-beta
Interventions
DRUG

Sodium Oxybate

Sodium oxybate h.s.

BEHAVIORAL

Sleep deprivation

36hr sleep deprivation

Trial Locations (1)

63108

Washington University Medical School, St Louis

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Aging (NIA)

NIH

lead

Washington University School of Medicine

OTHER

NCT02063217 - Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction | Biotech Hunter | Biotech Hunter